

EMCrit 354 - Reduced-Dose Systemic Peripheral Fibrinolysis in Massive Pulmonary Embolism
Jul 30, 2023
Exploration of reduced-dose fibrinolysis in massive pulmonary embolism, debate on optimal dosing, challenges in publishing device therapy trials, intricacies of balancing TPA and Heparin therapies, personalized dosing for improved outcomes.
Chapters
Transcript
1 2 3 4 5
Introduction
00:00 • 5min
Utilizing Reduced-Dose Systemic Peripheral Fibrinolysis in High-Risk Submassive Patients
05:25 • 20min
Exploring Disparities in Trial Promotion and Study Publication
25:20 • 2min
Managing Pulmonary Embolisms with TPA and Heparin
26:57 • 6min
Personalized Dosing and Management in Massive Pulmonary Embolism
32:32 • 3min